# S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction

> **NCT00086996** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 98 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** oxaliplatin
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00086996
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2009-08
- **Final completion:** 2011-08
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2013-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00086996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00086996, "S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00086996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*